ICD M34.9ORPHA:90291SSc

Scleroderma

Scleroderma (systemic sclerosis) is a rare autoimmune connective tissue disease characterised by fibrosis of the skin and internal organs, vascular abnormalities, and immune dysregulation. It ranges from limited cutaneous to diffuse forms with major organ involvement. Interstitial lung disease and pulmonary arterial hypertension are leading causes of disease-related mortality.

879
Articles
562
Trials (19 AU)
Updated
6 July 2026
Loading...

Common Questions

What is Scleroderma?

Scleroderma (systemic sclerosis) is a rare autoimmune connective tissue disease characterised by fibrosis of the skin and internal organs, vascular abnormalities, and immune dysregulation. It ranges from limited cutaneous to diffuse forms with major organ involvement. Interstitial lung disease and pulmonary arterial hypertension are leading causes of disease-related mortality.

How many clinical trials are available for Scleroderma?

RareWays currently indexes 562 clinical trials for Scleroderma, of which 158 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.

Where does the research data for Scleroderma come from?

RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.

Get research updates

Monthly email when new findings are published for Scleroderma.

No spam. Unsubscribe any time. Not medical advice.

This information is for general awareness only.

For guidance specific to your situation, please speak with your healthcare team.